142 related articles for article (PubMed ID: 37307764)
1. Beta blockers reduce uterine fibroid incidence in hypertensive women.
Fischer NM; Nieuwenhuis TO; Hazimeh D; Voegtline K; Singh B; Segars JH
Eur J Obstet Gynecol Reprod Biol; 2023 Aug; 287():119-125. PubMed ID: 37307764
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-Converting Enzyme Inhibitors Reduce Uterine Fibroid Incidence in Hypertensive Women.
Fischer NM; Nieuwenhuis TO; Singh B; Yenokyan G; Segars JH
J Clin Endocrinol Metab; 2021 Jan; 106(2):e650-e659. PubMed ID: 33035320
[TBL] [Abstract][Full Text] [Related]
3. Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study.
Borahay MA; Fang X; Baillargeon JG; Kilic GS; Boehning DF; Kuo YF
Am J Obstet Gynecol; 2016 Dec; 215(6):750.e1-750.e8. PubMed ID: 27371355
[TBL] [Abstract][Full Text] [Related]
4. Uterine fibroids and cardiovascular risk.
Uimari O; Auvinen J; Jokelainen J; Puukka K; Ruokonen A; Järvelin MR; Piltonen T; Keinänen-Kiukaanniemi S; Zondervan K; Järvelä I; Ryynänen M; Martikainen H
Hum Reprod; 2016 Dec; 31(12):2689-2703. PubMed ID: 27733532
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
6. Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer.
Stewart L; Glenn GM; Stratton P; Goldstein AM; Merino MJ; Tucker MA; Linehan WM; Toro JR
Arch Dermatol; 2008 Dec; 144(12):1584-92. PubMed ID: 19075141
[TBL] [Abstract][Full Text] [Related]
7. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
8. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A
Am J Obstet Gynecol; 2023 Mar; 228(3):320.e1-320.e11. PubMed ID: 36370871
[TBL] [Abstract][Full Text] [Related]
9. Preoperative medical therapy before surgery for uterine fibroids.
Lethaby A; Puscasiu L; Vollenhoven B
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
[TBL] [Abstract][Full Text] [Related]
10. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
11. Outcome of pregnancies in women with uterine leiomyomas identified by sonography in the first trimester.
Benson CB; Chow JS; Chang-Lee W; Hill JA; Doubilet PM
J Clin Ultrasound; 2001 Jun; 29(5):261-4. PubMed ID: 11486319
[TBL] [Abstract][Full Text] [Related]
12. Profibrotic interleukin-33 is correlated with uterine leiomyoma tumour burden.
Santulli P; Even M; Chouzenoux S; Millischer AE; Borghese B; de Ziegler D; Batteux F; Chapron C
Hum Reprod; 2013 Aug; 28(8):2126-33. PubMed ID: 23739220
[TBL] [Abstract][Full Text] [Related]
13. Hypertension, Cardiovascular Risk Factors, and Uterine Fibroid Diagnosis in Midlife.
Mitro SD; Wise LA; Waetjen LE; Lee C; Zaritsky E; Harlow SD; Solomon DH; Thurston RC; El Khoudary SR; Santoro N; Hedderson MM
JAMA Netw Open; 2024 Apr; 7(4):e246832. PubMed ID: 38625699
[TBL] [Abstract][Full Text] [Related]
14. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
15. Uterine fibroid incidence and growth in an ultrasound-based, prospective study of young African Americans.
Baird DD; Patchel SA; Saldana TM; Umbach DM; Cooper T; Wegienka G; Harmon QE
Am J Obstet Gynecol; 2020 Sep; 223(3):402.e1-402.e18. PubMed ID: 32105679
[TBL] [Abstract][Full Text] [Related]
16. Association of uterine fibroids with increased blood pressure: a cross-sectional study and meta-analysis.
Chen Y; Xiong N; Xiao J; Huang X; Chen R; Ye S; Tan X
Hypertens Res; 2022 Apr; 45(4):715-721. PubMed ID: 35169279
[TBL] [Abstract][Full Text] [Related]
17. Hypertension risk in Dutch women with symptomatic uterine fibroids.
Haan YC; Oudman I; de Lange ME; Timmermans A; Ankum WM; van Montfrans GA; Brewster LM
Am J Hypertens; 2015 Apr; 28(4):487-92. PubMed ID: 25241046
[TBL] [Abstract][Full Text] [Related]
18. A US population-based study of uterine fibroid diagnosis incidence, trends, and prevalence: 2005 through 2014.
Yu O; Scholes D; Schulze-Rath R; Grafton J; Hansen K; Reed SD
Am J Obstet Gynecol; 2018 Dec; 219(6):591.e1-591.e8. PubMed ID: 30291840
[TBL] [Abstract][Full Text] [Related]
19. Examining the relationship between uterine fibroids and dyspareunia among premenopausal women in the United States.
Moshesh M; Olshan AF; Saldana T; Baird D
J Sex Med; 2014 Mar; 11(3):800-8. PubMed ID: 24467730
[TBL] [Abstract][Full Text] [Related]
20. Uterine structural abnormality and intrauterine device malposition: analysis of ultrasonographic and demographic variables of 517 patients.
Gerkowicz SA; Fiorentino DG; Kovacs AP; Arheart KL; Verma U
Am J Obstet Gynecol; 2019 Feb; 220(2):183.e1-183.e8. PubMed ID: 30419198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
